FDA Cites Cancer Link In Proposed Tanning Bed Regs

Law360, New York (May 7, 2013, 1:03 PM EDT) -- The U.S. Food and Drug Administration stepped up efforts Monday to curb ultraviolet tanning products it has linked to higher occurrences of skin cancer, proposing a rule to increase the risk category of tanning beds and create new mandatory labeling requirements.

Under the new regulation, ultraviolet tanning lamps would be relabeled as “sunlamp products” and regulated as class II or “moderate risk” devices, obliging manufacturers to submit premarket notifications to the agency. The products are currently exempt from such notifications as “low risk” class I devices....
To view the full article, register now.